Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-2-4
pubmed:abstractText
Marginal zone B-cell lymphomas (MZLs) have been divided into 3 distinct subtypes (extranodal MZLs of mucosa-associated lymphoid tissue [MALT] type, nodal MZLs, and splenic MZLs). Nevertheless, the relationship between the subtypes is still unclear. We performed a comprehensive analysis of genomic DNA copy number changes in a very large series of MZL cases with the aim of addressing this question. Samples from 218 MZL patients (25 nodal, 57 MALT, 134 splenic, and 2 not better specified MZLs) were analyzed with the Affymetrix Human Mapping 250K SNP arrays, and the data combined with matched gene expression in 33 of 218 cases. MALT lymphoma presented significantly more frequently gains at 3p, 6p, 18p, and del(6q23) (TNFAIP3/A20), whereas splenic MZLs was associated with del(7q31), del(8p). Nodal MZLs did not show statistically significant differences compared with MALT lymphoma while lacking the splenic MZLs-related 7q losses. Gains of 3q and 18q were common to all 3 subtypes. del(8p) was often present together with del(17p) (TP53). Although del(17p) did not determine a worse outcome and del(8p) was only of borderline significance, the presence of both deletions had a highly significant negative impact on the outcome of splenic MZLs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1528-0020
pubmed:author
pubmed-author:ArcainiLucaL, pubmed-author:BaldiniLucaL, pubmed-author:BertoniFrancescoF, pubmed-author:BhagatGovindG, pubmed-author:CanzonieriVincenzoV, pubmed-author:CavalliFrancoF, pubmed-author:ChigrinovaEkaterinaE, pubmed-author:Dalla FaveraRiccardoR, pubmed-author:De CamposCassio PCP, pubmed-author:DirnhoferStephanS, pubmed-author:DoglioniClaudioC, pubmed-author:FacchettiFabioF, pubmed-author:FerreriAndrés J MAJ, pubmed-author:ForconiFrancescoF, pubmed-author:FranceschettiSilviaS, pubmed-author:GaidanoGianlucaG, pubmed-author:GascoyneRandy DRD, pubmed-author:GatteiValterV, pubmed-author:GoviSilviaS, pubmed-author:KangY HYH, pubmed-author:MarascaRobertoR, pubmed-author:MianMichaelM, pubmed-author:MollejoManuelaM, pubmed-author:NovakUrbanU, pubmed-author:PirisMiguel AMA, pubmed-author:PonzoniMaurilioM, pubmed-author:RancoitaPaola M VPM, pubmed-author:RinaldiAndreaA, pubmed-author:SoulierJeanJ, pubmed-author:ThieblemontCatherineC, pubmed-author:TibilettiMaria GraziaMG, pubmed-author:TripodoClaudioC, pubmed-author:TucciAlessandraA, pubmed-author:UccellaSilviaS, pubmed-author:ZuccaEmanueleE
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1595-604
pubmed:meshHeading
pubmed-meshheading:21115979-Adult, pubmed-meshheading:21115979-Aged, pubmed-meshheading:21115979-Aged, 80 and over, pubmed-meshheading:21115979-Chromosome Aberrations, pubmed-meshheading:21115979-Comparative Genomic Hybridization, pubmed-meshheading:21115979-DNA Fingerprinting, pubmed-meshheading:21115979-Female, pubmed-meshheading:21115979-Gene Expression Profiling, pubmed-meshheading:21115979-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21115979-Genome, Human, pubmed-meshheading:21115979-Humans, pubmed-meshheading:21115979-Lymphoma, B-Cell, Marginal Zone, pubmed-meshheading:21115979-Male, pubmed-meshheading:21115979-Middle Aged, pubmed-meshheading:21115979-Polymorphism, Single Nucleotide, pubmed-meshheading:21115979-Prognosis, pubmed-meshheading:21115979-Splenic Neoplasms, pubmed-meshheading:21115979-Young Adult
pubmed:year
2011
pubmed:articleTitle
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
pubmed:affiliation
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland, via Vincenzo Vela 6, Bellinzona, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't